JAMES FEDERICA: Open Payments
NPI 1003595901 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 49 payments from 13 companies in 2025. Trend: 2023 $204 · 2024 $641 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $225 |
| PFIZER INC. | 7 | $147 |
| Novo Nordisk Inc | 6 | $117 |
| Exact Sciences Corporation | 4 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $71 |
| Lilly USA, LLC | 3 | $48 |
| Corcept Therapeutics | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: PREVNAR 20, QULIPTA, Cologuard Collection Kit, VRAYLAR, Wegovy, BREZTRI, Korlym, Rybelsus.
Industry payments across NJ — which companies pay providers there.
